Economic Evaluations of Magnetic Resonance Image-Guided Radiotherapy (MRIgRT): A Systematic Review
Alessandra Castelluccia,
Pierpaolo Mincarone (pierpaolo.mincarone@irpps.cnr.it),
Maria Rosaria Tumolo,
Saverio Sabina,
Riccardo Colella,
Antonella Bodini,
Francesco Tramacere,
Maurizio Portaluri and
Carlo Giacomo Leo
Additional contact information
Alessandra Castelluccia: Radiation Oncology, Department of Radiotherapy, Hospital “A. Perrino”, ASL Brindisi, 72100 Brindisi, Italy
Pierpaolo Mincarone: Institute for Research on Population and Social Policies, National Research Council, 72100 Brindisi, Italy
Maria Rosaria Tumolo: Department of Biological and Environmental Sciences and Technology, University of Salento, 73100 Lecce, Italy
Saverio Sabina: MOVE-Mentis s.r.l., 47522 Cesena, Italy
Riccardo Colella: Department of Engineering for Innovation, University of Salento, 73100 Lecce, Italy
Antonella Bodini: Institute for Applied Mathematics and Information Technologies “E. Magenes”, National Research Council, 20133 Milan, Italy
Francesco Tramacere: Radiation Oncology, Department of Radiotherapy, Hospital “A. Perrino”, ASL Brindisi, 72100 Brindisi, Italy
Maurizio Portaluri: Radiation Oncology, Department of Radiotherapy, Hospital “A. Perrino”, ASL Brindisi, 72100 Brindisi, Italy
Carlo Giacomo Leo: MOVE-Mentis s.r.l., 47522 Cesena, Italy
IJERPH, 2022, vol. 19, issue 17, 1-21
Abstract:
Objectives: This review systematically summarizes the evidence on the economic impact of magnetic resonance image-guided RT (MRIgRT). Methods: We systematically searched INAHTA, MEDLINE, and Scopus up to March 2022 to retrieve health economic studies. Relevant data were extracted on study type, model inputs, modeling methods and economic results. Results: Five studies were included. Two studies performed a full economic assessment to compare the cost-effectiveness of MRIgRT with other forms of image-guided radiation therapy. One study performed a cost minimization analysis and two studies performed an activity-based costing, all comparing MRIgRT with X-ray computed tomography image-guided radiation therapy (CTIgRT). Prostate cancer was the target condition in four studies and hepatocellular carcinoma in one. Considering the studies with a full economic assessment, MR-guided stereotactic body radiation therapy was found to be cost effective with respect to CTIgRT or conventional or moderate hypofractionated RT, even with a low reduction in toxicity. Conversely, a greater reduction in toxicity is required to compete with extreme hypofractionated RT without MR guidance. Conclusions: This review highlights the great potential of MRIgRT but also the need for further evidence, especially for late toxicity, whose reduction is expected to be the real added value of this technology.
Keywords: economic evaluation; image-guided radiotherapy; adaptive radiation therapy; MRI-guided radiotherapy; systematic review (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.mdpi.com/1660-4601/19/17/10800/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/17/10800/ (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:17:p:10800-:d:901746
Access Statistics for this article
IJERPH is currently edited by Ms. Jenna Liu
More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager (indexing@mdpi.com).